QUIET LIFE

देश: आयरलैंड

भाषा: अंग्रेज़ी

स्रोत: HPRA (Health Products Regulatory Authority)

सक्रिय संघटक:

HUMULUS LUPULUS ; LEONURUS CARDIACA ; VALERIAN DRY HYDROALCOHOLIC EXTRACT PH.EUR.; PASSIFLORA INCARNATA ; THIAMINE HYDROCHLORIDE ; RIBOFLAVIN ; NICOTINAMIDE

थमां उपलब्ध:

GR Lane Health Products Ltd

ए.टी.सी कोड:

N05CM09

INN (इंटरनेशनल नाम):

HUMULUS LUPULUS ; LEONURUS CARDIACA ; VALERIAN DRY HYDROALCOHOLIC EXTRACT PH.EUR.; PASSIFLORA INCARNATA ; THIAMINE HYDROCHLORIDE ; RIBOFLAVIN ; NICOTINAMIDE

डोज़:

Per Cent

फार्मास्यूटिकल फॉर्म:

Tablets

प्रिस्क्रिप्शन प्रकार:

Product not subject to medical prescription

चिकित्सीय क्षेत्र:

Valerianae radix

प्राधिकरण का दर्जा:

Marketed

प्राधिकरण की तारीख:

1992-11-27

उत्पाद विशेषताएं

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Quiet Life Coated Tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Excipients:
Sucrose
167.77
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Coated Tablet (tablet).
Pink sugar coated round, biconvex coated tablet.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
To relieve irritability and exogenous stresses and strains and induce
relaxation.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Two tablets two to three times daily. Use should not exceed two weeks.
4.3 CONTRAINDICATIONS
Hypersensitivity to the active substance(s) or to any of the
excipients.
Patients with rare hereditary problems of fructose intolerance,
glucose-galactose malabsorption or sucrase-isomaltase
insufficiency should not take this medicine.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
The recommended dosage should not be exceeded.
MG/TABLET
Leonurus cardiaca powder (Motherwort)
34
Humulus lupulus powder (Hops)
75
Passiflora incarnata powder (Passiflora)
58
Valeriana Dry Hydroalcohotic extract
(equivalent to 50 mg_ Valeriana officinalis_ L. root)
12.5
Thiamine hydrochloride
0.71
Riboflavin
0.57
Nicotinamide
4.49
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_6_
_/_
_0_
_3_
_/_
_2_
_0_
_1_
_1_
_C_
_R_
_N_
_ _
_2_
_0_
_9_
_1_
_4_
_2_
_8_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None known.
4.6 FERTILITY, PREGNANCY AND LACTATION
Should not be taken by women w